c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation

Journal of Molecular Diagnostics

Volumn 7, Issue 2, 2005, Pages 252-257

  Yanagihori, Hirokatsu ^a   Oyama, Noritaka ^a   Nakamura, Koichiro ^a   Kaneko, Fumio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GENOMIC DNA; PHENYLALANINE; STEM CELL FACTOR; VALINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DNA SEQUENCE; FEMALE; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INCIDENCE; INFANT; JAPAN; MALE; MAST CELL; MISSENSE MUTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; URTICARIA PIGMENTOSA;

EID: 18744382426     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60552-1     Document Type: Article

References (21)

1. Metcalfe DD: Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991, 96:2S-4S
2. Azana JM, Torrelo A, Mediero IG, Zambrano A: Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 1994, 11:102-106
3. Taylor ML, Metcalfe DD: Kit signal transduction. Hematol Oncol Clin North Am 2000, 14:517-535
4. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993, 92:1736-1744
5. Buttner C, Henz BM, Welker P, Sepp NT, Grabbe J: Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 1998, 111:1227-1231
6. Longley BJ, Metcalfe DD: A proposed classification of mastocytosis incorporating molecular genetics. Hematol Oncol Clin North Am 2000, 14:697-701
7. Worobec AS, Semere T, Nagata H, Metcalfe DD: Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer 1998, 83:2120-2129
8. Longley Jr BJ, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ, Heitjan D, Ma Y: Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999, 96:1609-1614
9. Pullarkat VA, Pullarkat ST, Calverley DC, Brynes RK: Mast cell disease associated with acute myelold leukemia: detection of a new c-kit mutation Asp816His. Am J Hematol 2000, 65:307-309
10. Pignon JM, Giraudier S, Duquesnoy P, Jouault H, Imbert M, Vainchenker W, Vernant JP, Tulliez M: A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 1997, 96:374-376
11. Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD: A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 2004, 103:3222-3225
12. Vliagoftis H, Worobec AS, Metcalfe DD: The protooncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol 1997, 100:435-440
13. Davis LG, Dibner MD, Batte JF: Basic Methods in Molecular Biology. New York, Elsevier, 1986, pp 44-87
14. Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC: KIT mutations are common in testicular seminomas. Am J Pathol 2004, 164:305-313
15. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I: Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 1996, 12:312-314
16. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y: Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 1998, 19:323-324
17. Nagata H, Okada T, Worobec AS, Semere T, Metcalfe DD: c-kit mutation in a population of patients with mastocytosis. Int Arch Allergy Immunol 1997, 113:184-186
18. Beghini A, Tibiletti MG, Roversi G, Chiaravalli AM, Serio G, Capella C, Larizza L: Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 2001, 92:657-662
19. Sommer G, Agosti V, Ehlers I, Rossi F, Corbacioglu S, Farkas J, Moore M, Manova K, Antonescu CR, Besmer P: Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proc Natl Acad Sci USA 2003, 100:6706-6711
20. Ma Y, Zeng S, Metcalfe DD, Akin C, Dimitrijevic S, Butterfield JH, McMahon G, Longley BJ: The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood 2002, 99:1741-1744
21. Zermati Y, De Sepulveda P, Feger F, Letard S, Kersual J, Casteran N, Gorochov G, Dy M, Ribadeau Dumas A, Dorgham K, Parizot C, Bieche Y, Vidaud M, Lortholary O, Arock M, Hermine O, Dubreuil P: Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene 2003, 22:660-664